TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00019604

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Principal investigator left the institution.”

The sponsor’s own words in the registry.

Life of this trial

199820002002200420062008201020122014Started1998-08Registered2001-07-11Stopped2009-01Results posted2014-06-12

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
National Institutes of Health Clinical Center (CC)
Sponsor type
US National Institutes of Health
Conditions
Liver Cancer; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions
computed tomography; magnetic resonance imaging; positron emission tomography; radiofrequency ablation; radionuclide imaging; ultrasound imaging
Participants
44
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.